Factor Xa inhibition by rivaroxaban attenuates cardiac remodeling due to intermittent hypoxia.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of pharmacological sciences"
DOI: 10.1016/j.jphs.2018.07.002
Abstract: Patients with obstructive sleep apnea (OSA) have a high prevalence of atrial fibrillation (AF). Rivaroxaban, a coagulation factor Xa inhibitor, has recently been reported to show pleiotropic effects. This study investigated the influence of rivaroxaban… read more here.
Keywords: rivaroxaban attenuates; rivaroxaban; cardiac remodeling; factor ... See more keywords